University of Veterinary Medicine Vienna - Research portal

Diagrammed Link to Homepage University of Veterinary Medicine, Vienna

Heterologous prime boost vaccination against West Nile virus in horses

Abstract
In Europe, West Nile virus is an emerging mosquito-borne flavivirus with metazoonotic potential. While the virus depends on an enzootic life cycle in birds and competent arthropod vectors (mainly Culex species), horses and humans serve as accidental dead-end hosts. A subset of horses infected with West Nile virus develops neuroinvasive disease which is frequently life-threatening in naïve animals. Several effective vaccine types against lineage 2 West Nile virus prevailing in Europe, are licensed for horses. The immunity of horses and duration of neutralizing antibody response against WNV lineage 2 in response to vaccination, is however not extensively evaluated. For effective immunization usually sequential vaccinations in the form of prime-boost are required and traditionally consist of homologous boosts. Because of practicability, practitioners frequently choose a heterologous prime-boost approach which is not investigated for efficacy in horses in the case of immunization against lineage 2 WNV. The aims of this proposed study are to compare different prime-boost vaccinations against WNV in horses (homologous inactivated virus prime-boost, homologous recombinant canarypox vector prime-boost, canarypox prime- inactivated boost, and inactivated prime- canarypox boost) in regard to their induced immune response. Thus, the humoral immune response will be quantified using WNV neutralizing antibody titres against lineage 1 and 2. Results of this study will provide a better insight into the immune response against the less investigated WNV lineage 2 and answer questions that are highly relevant to daily equine veterinary practice: whether the sequential administration of differing vaccine types still gives an anamnestic immune response against the currently in Europe dominating WNV lineage 2 strains. Thus, vaccination schedules against WNV in endemic areas can be improved.
Lemma
Heterologous prime boost vaccination against WNV
Project leader
de Heus Phebe
Duration
01.02.22-30.09.24
Type of Research
Clinical research / study
Vetmed Research Units
University Equine Clinic, Clinical Unit of Equine Internal Medicine
Funded by
Stiftung Pro Pferd, Winterthurerstrasse 260, 8057 Zürich, Switzerland
© University of Veterinary Medicine ViennaHelp and DownloadsAccessibility statement